Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://andrewlxvl806376.blogerus.com/60796902/retaglutide-a-promising-glp-1-receptor-agonist